Array BioPharma Inc. (NASDAQ:ARRY) has an EPS estimate of $-0.22. Seven and 30 days ago, the EPS estimates reported were $-0.22 and $-0.22 respectively. But what was reported as EPS estimates for 60 and 90 days ago were $-0.22 and $-0.22 respectively. From 7 days ago, the percentage change in EPS estimates is 0 percent.
The up and down EPS revisions had respective numbers of 0 and 0 in the last 7 days. The number of up revisions of EPS in the last 30 and 60 days were 0, 0. The 90 and 120 last days had 0 and 0.
The last 30 and 60 day’s down revisions of EPS were 0 and 1. EPS_CNT_EST_REV_DOWN_LAST_90D:1841}} and 1 were the number of down revisions of EPS the last 90 and 120 days.
0 and 0 were the number of EPS revisions up and down respectively in the last 18 days.
Immediately prior to the announcement of actual earnings for the period ended 4, the mean EPS estimate is $-0.22 which is calculated while taking into account 6 EPS estimates. As announced on 2016-08-04, the actual EPS was $-0.17. The EPS surprise amount in per share dollar is $-0.02 while in percentage terms is -13.33 percent. Before the announcement of the actual earnings, the standard deviation of all EPS estimates stands at $0.13.
Quarterly Sales Estimates
All Annual sales estimates of Array BioPharma Inc. (NASDAQ:ARRY) has an arithmetic mean of $56.32 but $58.71 stands to be the median of all Annual sales estimates. The calculation of the estimate is by this company’s 3 analysts for the fiscal year 2017.
The highest annual estimates are $67.1 while the lowest are $43.15. All Annual sales estimates have the standard deviation of $12.152.
The increasing and decreasing of the number of analysts covering the stock and their sales estimate over the past week are at 3 and 3 respectively. The percentage change of the mean estimate is 0 percent for the past week.
Since one month ago, the increasing and decreasing number of analysts covering the stock and their sales estimate are 3 and 3 respectively. From the same one month ago, the percentage change of the mean estimate is 0 percent.
3 and 3 are the number of analysts covering the stock who have increased and decreased their sales estimate respectively since three month ago with the percentage change of the mean estimate being 133.499 percent from three month ago.
1 Chart Pattern Every Investor Should Know